Work

A multicenter phase II study of docetaxel, oxaliplatin, and bevacizumab in first-line therapy for unresectable locally advanced or metastatic non-squamous cell histology non-small-cell lung cancer (NSCLC)

Year: 2013

Type: article

Study design: Clinical Trial

Source: Cancer Chemotherapy and Pharmacology

DOI: 10.1007/s00280-013-2301-z

Authors: Luis E. Raez, Edgardo S. Santos, R. Timothy Webb, James Wade, Roger A. Brito, Melissa Karr, Andra Kennah, Barrett H. Childs

Institutions: Memorial Healthcare System, Boca Raton Regional Hospital, Decatur Memorial Hospital, Sylvester Comprehensive Cancer Center, Sanofi (United States)

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Sanofi, Genentech

OpenAlex ID: W2050891009

FWCI: 1.626

Cites: 38

Cited by: 11

Related to: 10